Definitive Contract W911NF22C0049
Award Date
9/29/22
Potential Completion Date
9/29/24
Potential Value
$1.1M
Funding Federal Agency
Research Development and Engineering Command
Contracting Federal Agency
ACC Aberdeen Proving Ground
Awardee
Chimerocyte, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
PSC Category
AJ11 - General Science And Technology R&D Services; General Science And Technology; Basic Research
Set-Aside Type
Total Small Business
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98195, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
STTR Phase II
Primary Consortia Member
Not listed
Similar Awards
The Department of the Army Materiel Command Research Development and Engineering Command awarded a Small Business Set Aside contract to Chimerocyte, Inc. for a Phase I STTR (Small Business Technology Transfer) research project. The contract, valued at $166,498.47, was awarded on December 7, 2020 and is scheduled for completion on June 6, 2021. The contract was issued in response to the Coronavirus COVID-19 National Interest Action code, indicating this research project is related to pandemic...
The Department of the Army Medical Command awarded a $249,960.43 Small Business Innovation Research (SBIR) Phase I purchase order to Chromologic LLC, a minority-owned, for-profit limited liability company, for research and development of "Radioprotection by JP4-039-MLV Nanoparticle Drugs." This work falls under the SBIR program, which provides funding to small businesses for early-stage research and development. Chromologic has previously conducted SBIR and Small Business Technology...
This contract was awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Chromologic LLC, a minority-owned small business, for research and development (R&D) efforts under the Small Business Innovation Research (SBIR) program Phase I. The contract, valued at $167,470.02, is for the development of a "Multi Injection Vial Anticontamination Cap (MIVA-CAP)." As this is a Phase I SBIR award, it represents the initial R&D stage...
This is a Small Business Innovation Research (SBIR) Phase II contract award to Chromologic LLC, a minority-owned, for-profit limited liability company. The $1,699,887.38 fixed-price level of effort contract was awarded by the Defense Microelectronics Activity (DMEA), a U.S. Department of Defense agency, and is designated as a total small business set-aside. The contract involves research and development of innovative technologies for the SBIR program, including work on portable oxygen generation...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command to Chromologic LLC, a minority-owned small business based in Monrovia, California. The contract has a firm fixed price of $149,823.91 and a completion date of April 24, 2018. As an SBIR Phase I award, this contract funds early-stage research and development efforts, likely focused on developing innovative medical technology solutions. Chromologic has a history of SBIR/STTR...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of the Army Medical Command to Innovital Systems Inc., a for-profit small business organization. The contract has a firm fixed price of $149,961.43 and is focused on research and development related to the SBIR program. As a prime contractor, Innovital Systems has received over $7 million in federal contracts since 2019 to deliver a range of goods and services to the Department of Defense, including...
This federal contract award is for Chromologic LLC's Phase II Small Business Innovation Research (SBIR) project focused on "Radioprotection by JP4-039-MLV Nanoparticle Drugs" under the U.S. Army Medical Command (MEDCOM). The $1,099,884.66 firm fixed-price contract has a period of performance through December 28, 2024 and is a set-aside for small businesses. As the prime contractor, Chromologic, a minority-owned limited liability company, will conduct research and development on medical...
This is a $150,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Army Medical Command (MEDCOM) to Critical Innovations LLC, a small business medical research and development company. The contract is for the SBIR DHP PHASE I PROPOSAL H161-011-0011, which involves the development of innovative solutions for military and pre-hospital healthcare applications. Critical Innovations specializes in advanced medical technologies such as wound treatment, hemorrhage...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Army Research, Development and Engineering Command (RDECOM) to Crimson Vista, Inc., a small business subchapter S corporation. The contract has a firm-fixed price of $149,262.75 and a period of performance ending on August 30, 2019. The contract is for SBIR Phase I research, which is the initial stage of the SBIR program that provides funding for exploring the feasibility of innovative technologies. As...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. government. The contract, with a ceiling value of $299,943.00, has been awarded to Lifetime Omics, Inc., a minority-owned, woman-owned, and small disadvantaged business. The contract is for research related to SBIR Topic 123, with a completion date of November 30, 2024. The contract is a definitive contract with a firm...